{"id":11651,"name":"NeoAntigen Treatment Navigator","purpose":"A software platform to help oncologists and researchers navigate the rapidly evolving landscape of individualized neoantigen cancer treatments, leveraging AI to analyze genomic data and predict treatment efficacy, based on Moderna's expansions.","profitable":1,"date_generated":"Friday April 2026 23:01","reference":"project-neoantigen-navigator","technology_advise":["Python","PostgreSQL","Difficult","Data"],"development_time_estimation_mvp_in_hours":220,"grade":8.2,"category":"healthcare","view_count":53,"similar_ideas":[{"id":11647,"name":"Neo-Antigen Therapy Risk Analyzer","grade":7.8,"category":"healthcare"},{"id":9220,"name":"NanoCancer Assist","grade":8.8,"category":"healthcare"},{"id":19698,"name":"Autism Research Navigator","grade":7.8,"category":"healthcare"},{"id":4971,"name":"Clinical Trial Signal Accelerator (CTSA)","grade":8.2,"category":"healthcare"},{"id":17780,"name":"Cancer Treatment Assistant (Frog Bacterium AI)","grade":6.3,"category":"healthcare"}],"source_headline":"Moderna faces dilemma in naming next-gen mRNA treatments"}